Patient Recruitment/Retention Featured Articles
-
What To Include In (And What To Leave Out Of) Your Clinical Trial Protocol
8/23/2023
To create a trial protocol that adequately captures your data requirements in a simple and streamlined fashion, consult early and often with patients and regulators to leverage their perspective.
-
How To Design A Clinical Trial Protocol With Patient And FDA Collaboration
8/18/2023
On a recent episode of Clinical Leader Live!, a panel of seasoned drug developers sat down to discuss the quintessential do’s and don’ts of modern clinical trials.
-
The Dos and Don’ts Of Patient Centricity
8/15/2023
New, exciting methodologies like DCTs and wearables can improve patient centricity, but only when participants’ lifestyles and preferences are kept in mind.
-
Recognizing Patients’ Wants And Needs Benefits Sponsors, Regulators, And, Of Course, Patients
8/11/2023
Most clinical trials fail to meet timelines, and the delay is typically caused by lagging patient enrollment. Patient advocates and consultants Richie Kahn and Jenn McNary say failed recruitment efforts often have to do with a fundamental mismatch between how a trial is designed and patients’ actual wants and needs.
-
Drug Development Must Meet Complex, Diverse Needs Of The Opioid Use Disorder Community
8/7/2023
With almost 80,000 opioid overdose deaths in 2022, the surge in opioid-related overdoses and deaths in the United States has continued at a relentless pace. Treatments are available, but with more diverse therapies and flexible trial designs, more patients will be able to begin their journey to recovery.
-
Improving Recruitment Through Community Engagement
8/1/2023
UPMC's Dr. Ken Ho shares personal insights about effective community engagement, which allowed him to increase recruitment in the Pitt Men's Study by 35% in just six months.
-
Adapting To The Recruiting Challenges Of Rare Diseases
7/31/2023
Senior VP and head of R&D for Takeda's Plasma-Derived Therapies Business Unit, Dr. Kristina Allikmets, describes the challenges recruiting in the rare (and ultra-rare) disease space.
-
Shared Knowledge & Shared Data Is Crucial To Developing Innovative Therapies For SCIs
7/7/2023
In this Q&A, Chief Science Officer Marco Baptista, Ph.D., discusses the Christopher & Dana Reeve Foundation's focus on and approach to data and knowledge sharing, as well as patient engagement, as it works to advocate for and fund the development of spinal cord injury (SCI) therapeutics.
-
Building Health Equity By Minimizing Barriers To Clinical Trial Participation
7/5/2023
The pharmaceutical industry continuously works to address the unmet needs of patients, including the need for therapies that work for as many people as possible. Yet, we continue to see a lack of diversity in clinical trials. Janssen's Lisa Lewis details how we can all come together to improve patient diversity and improve outcomes for all people.
-
Collaborating With Patients To Design More Effective Hybrid Trials
6/23/2023
Every clinical trial has the same goal: deliver an effective therapy that improves patient lives. One route there is surprisingly straightforward: place patient needs front and center.